IL17A and dermatitis: Zhang, et al. in a recent study reported that hUCMSCs-Exo could inhibit psoriasis-like skin inflammation by suppressing the expression of IL-17, IL-23, and CCL20, thereby inhibiting the phosphorylation of signal transducer and activator of transcription 3 (STAT3) [131].